ADMA Biologics President and CEO Adam S. Grossman sold 21,000 common shares at $13.72 each on November 16, 2026.

Grossman also exercised stock options to acquire 15,000 common shares at $5.4 each.

His direct beneficial ownership totaled 2,064,777 common shares following the transactions.

ADMA Biologics President and CEO Adam S. Grossman Reports Sale of $288,120 in Common Shares

ADMA Biologics President and CEO Adam S. Grossman Reports Sale of $288,120 in Common SharesADMA Biologics President and CEO Adam S. Grossman sold 21,000 common shares at $13.72 each on November 16, 20
ADMA Biologics President and CEO Adam S. Grossman Reports Sale of $288,120 in Common Shares

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet